Billam announces that one of its investee companies, EiRx Therapeutics Limited,
is in advanced stages of floating on the Alternative Investment Market of the
London Stock Exchange and is hopeful of achieving this by the end of December
2003.
Billam holds approximately 36% of EiRx Therapeutics Limited's share capital. The
aggregate cost of this investment is currently valued in Billam's balance sheet
at 2.2 million.
Good News at last ! Lets hope the share price strengthens over the near term.
Any one into ERX ?
I got in @7.5p (x30k shares).. company is looking good.